Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Axon guidance receptor tyrosine kinases, notably Trk and RET family receptors, are transmembrane proteins that combine ligand-dependent tyrosine kinase activity and crucial roles in neural development. Upon binding their specific growth factor ligands (such as neurotrophins for Trk, GDNF for RET), these receptors dimerize and activate intracellular signaling cascades, promoting neuronal survival, differentiation, growth cone dynamics, and overall axonal pathfinding. Dysregulation via gene fusions or mutations leads to diverse disease states, particularly a range of malignancies and developmental disorders, making these receptors high-priority therapeutic and diagnostic targets.
Kinase inhibition (competitive ATP binding inhibition); Prevention of signal transduction (blocking phosphorylation cascades); Induction of apoptosis in malignant cells
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Axon guidance receptor tyrosine kinase.